BackAchilles Therapeutics Plc Overview
Achilles Therapeutics Plc - ADR

Achilles Therapeutics Plc Discounted Cash Flow

DCF Analysis for ACHL.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$3.18

Current Fair Value

$3.18
114.5% Upside

Undervalued by 114.5% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading